Position in GILD
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$593,036,351
+$75,012,060 QoQ
Shares Held
4,255,122
+0.8% QoQ
Ownership
0.343%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
5 quarters on record
Voting authority
Sole 81.1355820115146.ToString("F0")%
Shared 0.ToString("F0")%
None 18.864417988485407.ToString("F0")%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Boston Partners holds $2,940,069,361 across 12 Drug Manufacturers - General names. GILD ranks #2 (20.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
3,434,210 | $746,906,331 | |
| 2 | GILD |
Gilead Sciences, Inc.
This page
|
4,255,122 | $593,036,351 | |
| 3 | AZN |
Astrazeneca PLC
|
2,093,896 | $412,958,167 | |
| 4 | JNJ |
Johnson & Johnson
|
1,558,577 | $380,978,561 | |
| 5 | BIIB |
Biogen Inc.
|
1,700,078 | $311,675,298 | |
| 6 | AMGN |
Amgen Inc
|
643,175 | $226,301,122 | |
| 7 | SNY |
Sanofi
|
3,599,284 | $173,413,502 | |
| 8 | MRK |
Merck & Co., Inc.
|
641,766 | $77,198,031 |
All Filings in GILD
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $593,036,351 | 4,255,122 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $518,024,291 | 4,220,501 | Shares | Defined | 2026-02-13 | |
| 2020-09-30 | $281,574 | 4,456 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,921,730 | 24,977 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $75,605,684 | 1,011,312 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||